Showing results (781-790 of 1,340) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|September 6, 2021
Inhibition of microglial EZH2 leads to anti-tumoral effects in pediatric diffuse midline gliomasLily Keane, Mathilde Cheray, Dalel Saidi, et al.
Neuro-Oncology Advances|December 1, 2022
Glioma stem cells activate platelets by plasma-independent thrombin production to promote glioblastoma tumorigenesisAnthony R Sloan, Christine Lee-Poturalski, Harry C Hoffman, et al.
Neuro-Oncology Advances|June 30, 2022
Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysisMueez Waqar, Federico Roncaroli, Eric J Lehrer, et al.
Neuro-Oncology Advances|January 12, 2023
Corrigendum to: A novel fully automated MRI-based deep-learning method for classification of 1p/19q co-deletion status in brain gliomasChandan Ganesh Bangalore Yogananda, Bhavya R Shah, Frank F Yu, et al.
Neuro-Oncology Advances|May 25, 2022
Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium reportMariko DeWire, Margot Lazow, Olivia Campagne, et al.
Neuro-Oncology Advances|May 20, 2022
Phase II study of intravenous etoposide in patients with relapsed ependymoma (CNS 2001 04)John R Apps, Shanna Maycock, David W Ellison, et al.
Neuro-Oncology Advances|May 20, 2022
Survival rates of children and young adolescents with CNS tumors improved in the Netherlands since 1990: A population-based studyRaoull Hoogendijk, Jasper van der Lugt, Dannis van Vuurden, et al.
Neuro-Oncology Advances|June 16, 2021
The role of RB1 alteration and 4q12 amplification in IDH-WT glioblastomaAntonio Dono, Arvind V Ramesh, Emily Wang, et al.
Neuro-Oncology Advances|July 14, 2021
Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysisIyad Alnahhas, Mouaz Alsawas, Appaji Rayi, et al.
Neuro-Oncology Advances|May 22, 2023
Current approaches in enhancing TRAIL therapies in glioblastomaMorrent Thang, Clara Mellows, Alison Mercer-Smith, et al.
Pageof 134